Filing Details

Accession Number:
0001140361-16-047513
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-11 17:50:06
Reporting Period:
2015-02-09
Filing Date:
2016-01-11
Accepted Time:
2016-01-11 17:50:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509261 Antriabio Inc. ANTB Pharmaceutical Preparations (2834) 273440894
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314773 C Nevan Elam 1450 Infinite Drive
Louisville CO 80027
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-09 842,949 $0.00 0 No 4 S Indirect Konus Advisory Group, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Konus Advisory Group, Inc.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Warrant to Purchase Common Stock Disposition 2015-02-09 39,117 $0.00 39,117 $1.25
Common Shares Series A Convertible Preferred Stock Acquisiton 2015-12-10 76,923 $1.95 76,923 $1.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-03-31 2019-03-31 No 4 S Indirect
76,923 2015-12-10 No 4 P Direct
Footnotes
  1. Reported securities were held by Konus Advisory Group, Inc., of which reporting person is significant holder, managing member & director. On Feb. 9, 2015, as part of extinguishment of $1,441,795 Konus debt, reported securities were transferred in entirety (giving effect to 1 for 8 reverse split). Reporting person no longer maintains voting or dispositive power of Issuer's shares & warrants previously held by Konus.
  2. The Series A Preferred Stock is convertible into common stock of Issuer at price per share of $1.95, subject to terms and conditions of Private Placement Memorandum dated November 3, 2015.
  3. The Series A Preferred Stock has no expiration date.